Dermatology NewsStudy finds secukinumab effective for moderate to severe scalp psoriasisAugust 9, 2017PsoriasisPsoriatic Arthritis
Dermatology NewsAlopecia may be permanent in one in four pediatric HSCT patientsAugust 2, 2017PediatricsHair & NailsPsoriasis
Dermatology NewsFirst interchangeability study for an adalimumab biosimilar has begunJuly 31, 2017PsoriasisPsoriatic Arthritis
Dermatology NewsUnresolved fatigue lingers for most PsA patientsJuly 17, 2017Psoriatic ArthritisPsoriasis
Dermatology NewsChildren with psoriasis face multitude of comorbiditiesJuly 15, 2017PsoriasisPediatricsPsoriatic Arthritis
Dermatology NewsIxekizumab helps PsA patients who failed a TNFiJuly 14, 2017Psoriatic ArthritisPsoriasis
Dermatology NewsFirst IL-23 blocker, guselkumab, earns FDA approval for psoriasisJuly 13, 2017PsoriasisPsoriatic Arthritis
Dermatology NewsComorbidities in psoriatic arthritis flag worse prognosisJuly 8, 2017PsoriasisPsoriatic Arthritis
Dermatology NewsFDA approves abatacept for adults with psoriatic arthritisJuly 7, 2017PsoriasisPsoriatic Arthritis
Dermatology NewsEarly phase III data positive for adalimumab biosimilar, for both psoriasis and PsAJuly 1, 2017Psoriatic ArthritisPsoriasis
Dermatology NewsTWEAKing inflammation: Studies reflect potential treatment target for psoriasis, atopic dermatitisJune 28, 2017Autoimmune DiseasesPsoriasisAtopic Dermatitis
Dermatology NewsPain often persists despite biologic treatment in PsAJune 16, 2017Psoriatic ArthritisPsoriasis
_web.jpg)
